| Human Continuum | seed | $5.0M | | Jun 11, 2026 |
| Adial Pharmaceuticals Acquires Azora Therapeutics and | | $64.0M | | Jun 11, 2026 |
| Edesa Biotech | | $3.5M | | Jun 11, 2026 |
| FESARIUSTHERAPEUTICS | series a | $20.0M | | Jun 10, 2026 |
| Fesarius Therapeutics | series a | $20.0M | Jefferson Life SciencesEmpire State Development’s NY Ventures | Jun 10, 2026 |
| Goldenrod Therapeutics: $6.5 Million Seed | seed | $6.5M | | Jun 10, 2026 |
| Beren Therapeutics | | $300.0M | | Jun 10, 2026 |
| SonoThera | series b | $125.0M | | Jun 10, 2026 |
| Parabilis Medicines | | $670.0M | | Jun 10, 2026 |
| Rejuvenate Bio | | $6.0M | VCapital | Jun 9, 2026 |
| Austrian DeepTech startup Invisible-Light Labs | pre seed | $1.5M | | Jun 9, 2026 |
| Pharma Funding Roundup: City Therapeutics | series b | $99.5M | | Jun 9, 2026 |
| City Therapeutics | series b | $99.5M | | Jun 8, 2026 |
| Spain: Ona Therapeutics | series b | $86.6M | | Jun 4, 2026 |
| Ona Therapeutics | series b | $86.6M | | Jun 4, 2026 |
| POP Biotechnologies | | $9.7M | | Jun 4, 2026 |
| New heights for NewLimit as anti-aging biotech | | $435.0M | | Jun 2, 2026 |
| Longevity startup NewLimit | | $435.0M | | Jun 2, 2026 |
| Tavo Biotherapeutics | series a | $17.0M | | Jun 2, 2026 |
| Fierce Biotech Fundraising Tracker '26: Ona | series b | $86.6M | | Jun 2, 2026 |
| hephaistos.bio | | $161.0K | | Jun 1, 2026 |
| developing tooth-regrowing drug | | $5.3M | | May 30, 2026 |
| Mykor: £4 Million | | $4.0M | Clean Growth Fund | May 29, 2026 |
| Biotechnology firm | | $4.0M | | May 29, 2026 |
| Company | | $23.6M | | May 28, 2026 |
| Company | | $23.6M | | May 28, 2026 |
| Secretome Therapeutics: $30 Million Series A | series a | $30.0M | | May 28, 2026 |
| North Texas' Secretome Therapeutics | series a | $30.0M | | May 28, 2026 |
| Secretome Therapeutics | series a | $30.0M | | May 28, 2026 |
| Perceptic | seed | $9.0M | Accel | May 28, 2026 |
| AI-native pharma marketing startup Solstice | | $21.0M | | May 28, 2026 |
| Bristol’s female-founded BioTech startup Mykor | | $4.6M | Clean Growth Fund | May 27, 2026 |
| Bristol’s female-founded Mykor | | $4.6M | Clean Growth Fund | May 27, 2026 |
| iFAST Diagnostics | | $5.0M | | May 27, 2026 |
| Mykor | | $4.0M | | May 27, 2026 |
| Texas biotech | | $7.5M | | May 27, 2026 |
| Perceptic | seed | $12.0M | | May 26, 2026 |
| Cartesian Therapeutics | | $150.0M | | May 26, 2026 |
| Kane Biotech | | $1.2M | | May 26, 2026 |
| Ex-Palantir AI execs | seed | $12.0M | | May 26, 2026 |
| StrainX | | $13.0M | | May 25, 2026 |
| StrainX Bioworks | | $13.0M | Prime Venture PartnersPrime Venture | May 25, 2026 |
| Prime Venture | | $13.0M | | May 25, 2026 |
| Oorja Bio: $30 Million Series A | series a | $30.0M | | May 23, 2026 |
| Sound Wave Innovation: $17 Million | series c | $17.0M | | May 22, 2026 |
| Sensei Biotherapeutics Acquires Faeth Therapeutics | series b | $200.0M | | May 22, 2026 |
| Neurosoft Bioelectronics: $7.5 Million Seed | seed | $7.5M | | May 22, 2026 |
| Novo-Backed Biotech Hemab | | $301.5M | | May 22, 2026 |
| Imperagen | seed | $5.0M | PXN VenturesIQ CapitalNorthern Gritstone+1 | May 21, 2026 |
| Manchester Imperagen | seed | $5.8M | PXN Ventures | May 21, 2026 |